Related Experiment Video
Updated: Jun 16, 2026

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
Published on: July 18, 2013
Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications
Allison H Bartlett1, Pyong Woo Park
1Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
Microbial pathogens use proteoglycans, which are cell surface molecules, to infect host cells. Disrupting these interactions with glycosaminoglycan (GAG) antagonists can inhibit pathogen invasion and reduce disease.
Area of Science:
- Microbiology
- Molecular Biology
- Pathogenesis
Background:
- Proteoglycans, composed of glycosaminoglycan (GAG) chains and core proteins, are crucial for cell surface and extracellular matrix functions.
- Many microbial pathogens exploit proteoglycans for critical steps in infection, including adhesion, invasion, and dissemination.
- Pathogen interactions with proteoglycans significantly influence the onset, progression, and outcome of infectious diseases.
Purpose of the Study:
- To investigate the role of proteoglycan-pathogen interactions in microbial pathogenesis.
- To understand how specific virulence factors mediate these interactions.
- To explore the therapeutic potential of targeting proteoglycan-pathogen interactions.
Main Methods:
- Review of existing literature on microbial pathogenesis and proteoglycan function.
- Analysis of studies involving GAG-binding pathogens and their interactions with host proteoglycans.
- Examination of experimental evidence, including mutagenesis, enzymatic treatments, and the use of GAG antagonists.
Main Results:
- Microbial pathogens utilize proteoglycans for adhesion, invasion, cell-to-cell spread, systemic dissemination, and immune evasion.
- Specific virulence factors mediate pathogen interactions with proteoglycans, impacting infection dynamics.
- Reduced GAG expression significantly impairs pathogen attachment and invasion.
- GAG antagonists effectively inhibit microbial attachment and host cell entry in vitro and reduce virulence in vivo.
Conclusions:
- Proteoglycan-pathogen interactions are biologically significant in infectious diseases.
- Targeting these interactions, particularly via GAG antagonists, presents a promising strategy for therapeutic intervention against microbial infections.
Related Concept Videos
Colonisation of Pathogens
Determinants of Bacterial Pathogenicity and Virulence
Proteoglycans
Matrix Proteoglycans and Glycoproteins
Glycocalyx and its Functions
Components of...
Microbial Interactions: Parasitism

